EGFR and non-small cell lung carcinoma: This may be attributed to the higher prevalence of EGFR mutations in Asian patients with NSCLC compared to European and American populations (Lynch et al., 2004; Paez et al., 2004; Pao et al., 2004; Melosky et al., 2022; Tan and Tan, 2022).